CLOs on the Move

Richman Root Delaney MD

www.richmanrootdelaney.com

 
Richman Root Delaney MD is a Waterford, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Hillsboro Medical Ctr

Hillsboro Medical Ctr is a Hillsboro, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

REE Medical

REE Medical is a company that provides top quality medical evaluations for veterans and their families to help them get the disability benefits they deserve.

Sport

Sport is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Windsor Health Group

Windsor Health Plan, Inc. is a Medicare Advantage plan with a Medicare contract, and a Medicare-approved Part D Sponsor, whose core purpose is to improve health and well being, peace of mind and financial security for our members when navigating health care coverage options. A partnership between Windsor Health Plan and Sterling Life Insurance Company since 2011, the organization can now provide more resources, member support and plan options for Medicare Advantage beneficiaries and is a leader in the provision of health care to Medicare- and Medicaid-eligible members seeking to enhance their quality of life. Windsor Health Plan manages government sponsored health plans and provides specialty managed care services to insurance providers and to health care providers. Windsor Health Plan is a division of Windsor Health Group, with corporate offices in Atlanta and operational offices in Nashville, Tenn. and Bellingham, Wash., as well as regional offices throughout the United States.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.